Insider · CIK 0001964148
Nicholas Corcoran
Files at TMDX (TransMedics Group, Inc.). First filing May 8, 2024, latest Mar 4, 2026.
In brief
Nicholas Corcoran files SEC Form 4 as officer at TMDX (TransMedics Group, Inc.). Since May 8, 2024, Nicholas Corcoran has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.6M, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; Nicholas Corcoran has 0, so none is measured yet.
The newest scored trade: sold $413k of TMDX on Mar 2, 2026, filed Mar 4, 2026, scored 46 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $413k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TMDX: TransMedics Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | TransMedics Group, Inc. | $413k 2,966 shares | -9% | +128% from low-2% from high | |
| 35Weak | TMDXsell TransMedics Group, Inc. | $1.8M 10,000 shares | -32% | +379% from low0% from high | |
| 51Moderate | TransMedics Group, Inc. | $419k 3,222 shares | -13% | +261% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | 10,000 0.03% of outstanding | $1.8M | Aug 27, 2024 | none |
| May 6, 2024 | TMDX TransMedics Group, Inc. | 3,222 0.01% of outstanding | $419k | May 6, 2024 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +11,727 | $0.00 | $0 | 41,558 | Jul 14, 2026 |
| Jul 10, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,784 | $0.00 | $0 | 17,784 | Jul 14, 2026 |
| Jan 23, 2026 | TMDX TransMedics Group, Inc. | FTax withholding Common Stock | -984 | $135.30 | $133k | 32,797 | Mar 4, 2026 |
| Mar 2, 2026 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock | -2,966 | $139.12 | $413k | 29,831 | Mar 4, 2026 |
| Feb 24, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +12,676 | $0.00 | $0 | 33,781 | Feb 26, 2025 |
| Feb 24, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +19,079 | $0.00 | $0 | 19,079 | Feb 26, 2025 |
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock | +7,810 | $66.10 | $516k | 28,915 | Aug 29, 2024 |
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock | +2,190 | $83.14 | $182k | 31,105 | Aug 29, 2024 |
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock | -10,000 | $176.02 | $1.8M | 21,105 | Aug 29, 2024 |
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -7,810 | $0.00 | $0 | 11,922 | Aug 29, 2024 |
| Aug 27, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,190 | $0.00 | $0 | 15,442 | Aug 29, 2024 |
| May 6, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock | -3,222 | $129.91 | $419k | 21,105 | May 8, 2024 |
| Feb 23, 2024 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +11,441 | $0.00 | $0 | 24,327 | Feb 27, 2024 |
| Feb 23, 2024 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,632 | $0.00 | $0 | 17,632 | Feb 27, 2024 |
Questions about Nicholas Corcoran
Answered from the filings on this page, as of the latest one.
Is Nicholas Corcoran buying or selling?
In the last 12 months Nicholas Corcoran reported 0 open-market buys worth $0 and 1 open-market sell worth $413k on SEC Form 4; the latest was sold $413k of TMDX on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Nicholas Corcoran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicholas Corcoran has 0.
Where does Nicholas Corcoran file Form 4?
Nicholas Corcoran has filed Form 4 at TMDX (TransMedics Group, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.